Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.
Morrow Sodali is serving as the information agent for this transaction.
Download the pdf to see the Wall Street Journal ad.
Related News
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right